about
High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007.The risk of renal disease is increased in lambda myeloma with bone marrow amyloid depositsAge but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden.Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study.Real-world data on first relapse of acute lymphoblastic leukemia in patients >55 years.High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in SwedenCarfilzomib-induced hemolysis is noticeably common but rarely shows features of thrombotic microangiopathy: A retrospective studySurvival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry
P50
Q36216252-D7655552-B2B6-4EC9-9D0C-0C83FD7C200EQ37693762-DAEC628C-88EB-46A1-B739-2D8498B2B4B7Q40238184-2CDCD222-2732-4746-8017-12A9B02A638CQ41137752-1DA750BD-0DF3-4979-AF5F-912D8AA46E25Q44783681-7279EEBC-8CB7-4A3E-A20B-C3D90249A311Q48220624-327D28EA-69EA-4BBA-84DC-8337E3FBD822Q87130047-C0E51B37-9545-4102-A4AA-9F2CA9824F5EQ89961415-BA759135-FAAE-4084-9404-52356730D598Q91915097-BD55D302-8AF3-4431-8F61-9C1BC22DD976
P50
description
researcher ORCID: 0000-0002-0283-4418
@en
wetenschapper
@nl
name
Piotr Kozlowski
@ast
Piotr Kozlowski
@en
Piotr Kozlowski
@es
Piotr Kozlowski
@nl
type
label
Piotr Kozlowski
@ast
Piotr Kozlowski
@en
Piotr Kozlowski
@es
Piotr Kozlowski
@nl
prefLabel
Piotr Kozlowski
@ast
Piotr Kozlowski
@en
Piotr Kozlowski
@es
Piotr Kozlowski
@nl
P106
P21
P31
P496
0000-0002-0283-4418